CBIO

Crescent Biopharma, Inc. Common Stock
CBIO

Overview Fund Activity

29 hedge funds and large institutions have $79.3M invested in Crescent Biopharma, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
14
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Franklin Resources
1
Franklin Resources
California
$5.78M
2
BCM
2
Bridgeway Capital Management
Texas
$628K
3
Wells Fargo
3
Wells Fargo
California
$143K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$348K
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$160K

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$1.62M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
SIM
3
Spark Investment Management
New York
$264K
4
Morgan Stanley
4
Morgan Stanley
New York
$32K
5
Citigroup
5
Citigroup
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$6K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$5K -$6.67K -12 -57%
TCOV
28
Trust Company of Vermont
Vermont
$1K – – –
Alyeska Investment Group
29
Alyeska Investment Group
Illinois
– -$196K -350 Closed
Citigroup
30
Citigroup
New York
– -$11K -20 Closed
UBS Group
31
UBS Group
Switzerland
– -$8K -14 Closed
1
2